Health System AI Intake Process: How to Triage AI Requests From Clinicians

Why health systems need a formal AI intake path

Clinicians are increasingly identifying AI tools, copilots, and agents that could support documentation, triage, communication, administrative work, research workflows, or patient care operations. Without a formal intake path, those requests can arrive through informal channels, individual departments, vendor relationships, innovation programs, or unsanctioned experimentation.

A formal intake process gives the health system a consistent way to evaluate AI requests before they become pilots or production systems. It helps governance teams understand what the tool is intended to do, who will use it, whether it will touch PHI, whether it will affect clinical decisions, and whether it will connect to the EHR or other operational systems.

The goal is not to slow all requests down. The goal is to quickly separate low-risk exploration from requests that require privacy, security, clinical, legal, IT, or executive review.

Required intake information for clinician-submitted AI requests

The intake form should collect enough information to classify the request without forcing every submitter to complete a full procurement or technical assessment on day one. A practical intake should include:

• Use case and users: Clinical problem, department, user roles, workflow location, and expected operational benefit.
• Clinical impact: Whether output is documentation-only, advisory, diagnostic, treatment-related, or patient-facing.
• Data sources: PHI access, EHR data, notes, images, messages, claims, device data, or de-identified data.
• Integration scope: EHR integration, APIs, messaging systems, identity systems, clinical tools, or agent actions.
• Model and vendor details: Model provenance, hosting model, validation materials, update behavior, and available transparency documentation.
• Deployment expectation: Exploration, limited pilot, production use, patient interaction, or enterprise-wide availability.

Risk-tier criteria for clinician AI requests

Health systems should classify AI requests by the type of clinical impact, data exposure, integration depth, and operational control involved. A risk tier does not need to be final at submission. It can be provisional during initial screening and updated during review.

Stakeholder routing and approval ownership

A health system AI request triage workflow should separate initial classification from full approval. This prevents every request from going through the same heavy process while still ensuring that high-risk requests are escalated. The workflow should also define service-level expectations. If the process is opaque or too slow, clinicians and departments may return to informal procurement or unsanctioned experimentation.

A common model is to use a central intake queue managed by an AI governance or clinical informatics function. That team performs an initial screen, assigns a provisional risk tier, and routes the request to required reviewers.

When intake should trigger runtime governance

Initial approval is a point-in-time control. It determines whether a requested AI tool or agent can proceed to pilot or deployment under defined conditions. Runtime governance addresses what happens after the tool is active: who can use it, what data it can access, what tools it can call, what actions it can take, and how usage is logged and monitored.

Runtime controls become especially relevant when a tool or agent has access to PHI, connects to EHR or workflow systems, supports multiple user roles, calls external tools, or performs actions beyond generating text. In those cases, governance teams should not approve the request in abstract. They should approve a bounded operating model: permitted users, permitted data classes, allowed tools, disallowed actions, audit logging requirements, and monitoring expectations.

For AI agents, the intake process should be explicit about identity and permissions. An agent that can retrieve patient information, draft messages, call APIs, or coordinate with other agents should not inherit broad user privileges by default. Least privilege, tool approval workflows, agent identity, and audit logging are core design considerations. The same applies to MCP-connected tools or other agent tool interfaces. The health system should know which tools are approved, which permissions are granted, and which actions require human confirmation.

Trussed AI provides runtime governance and security capabilities for enterprise AI agents, including runtime policy enforcement, runtime monitoring, agent identity, agent permissions, least privilege, AI tool governance, MCP security, and audit logging. In a health system intake model, these capabilities become relevant after a request is approved for controlled pilot or deployment, particularly when agent behavior, system access, or PHI exposure must be governed continuously.

Implementation checklist for AI governance leaders

Use the intake process to establish a review record that can carry forward into pilot controls, deployment approval, and runtime oversight.

• Capture the intended use, clinical workflow, user roles, and expected operational benefit.
• Identify whether the AI tool is documentation-only, advisory, diagnostic, treatment-related, or patient-facing.
• Document PHI access, EHR data access, clinical notes, images, messages, claims, device data, and de-identified data use.
• Record EHR integration, API access, messaging systems, identity systems, clinical tools, and agent actions.
• Collect model provenance, hosting model, validation materials, update behavior, and available transparency documentation.
• Classify whether the request is exploration, limited pilot, production use, patient interaction, or enterprise-wide availability.
• Route PHI-connected requests to security and privacy review.
• Route workflow and clinician accountability questions to clinical informatics.
• Route regulatory triggers, data use terms, and vendor obligations to compliance or legal review.
• Route integration feasibility, identity, logging, supportability, and operational ownership to IT review.
• Escalate high-risk patient-care pilots to the clinical AI governance committee or equivalent executive forum.
• Carry approved scope into runtime access controls, monitoring, permissions, tool governance, and audit logging.